BERKELEY, Calif. and CAMBRIDGE, Mass., Sept. 29, 2023 /PRNewswire/ -- Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to modulate gene expression, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results